Introduction
The oxidative metabolism of endogenous steroids (1) and xenobiotics such as nitrosamines (2), benzo[ alpyrene (3), hexamethylphosphoramide (4), phenacetin (5) . and aminopyrine (6) in the nasal mucosa is catalyzed by members of the cytochromes P450 superfamily (4, (7) (8) (9) . In contrast to hepatic cytochrome P450, nasal cytochrome P450 activity is not increased after exposure to inducers such as phenobarbital, 3-methylcholanthrene, and benzo[a]pyrene (lo) , and olfactory P450 activity is more sensitive to inhibition by metyrapone and alpha-naphthoflavone (ll), suggesting that the nasal mucosa contains forms of cytochromes P450 that are distinct from those found in the liver. Indeed, a number of cytochromes P450 are present in the nasal mucosa, including several unique forms that appear to be expressed only in nasal tissues of rats (12) and rabbits (13) . The presence of these cytochrome P450 isoforms may Supported by USPHS Grants GM33253 increased antLP450 1Al binding in Bowman's glands and in the olfactory and respiratory epithelia, and dramatically enhanced benzo[a]pyrene hydroxylase activity in the epithelia and the subepithelial ducts and glands in both the olfactory and respiratory regions. In contrast to its effects on cytochrome P450 1A1, A r d o r 1254 produced a considerably greater induction of hydroxylase activity in the respiratory region, especially in the seromucous glands, than in the olfactory region. These results suggest that Ardor 1254 treatment also induces other forms of cytochrome P450 in the respiratory region of the nasal mucosa. (]Hisrochem Cyro-&em 41:877-885, 1993) KEY WORDS: Cytochrome P45O Rat nasal mucosa; Immunohistochemical localization; aryl hydrocarbon hydroxylase. account for the nasal tissue-specific toxicities that result from exposure to certain xenobiotics. These toxicities range from a selective necrosis of the olfactory epithelium (14) to tumor formation The nasal mucosa is a relatively complex and heterogeneous tissue which consists of olfactory and respiratory regions. The lamina propria of the olfactory region contains Bowman's glands and is covered with a pseudostratified, columnar epithelium composed of basal, sustentacular, and bipolar olfactory neuronal cells. The columnar epithelium covering the respiratory region is composed of ciliated and non-ciliated columnar cells, goblet cells, and basal cells. Seromucous glands and duct cells are found in the lamina propria in the respiratory region. Despite the fact that the balance between xenobiotic-activating and -detoxicating pathways in each cell type should determine, in part, which nasal mucosal cells would be most susceptible to damage produced as a consequence of the formation of cytotoxic or carcinogenic metabolites from various xenobiotics, the metabolic capabilities of each of these morphologically and functionally different cell types are largely unknown. Characterization of the enzymatic capabilities of individual cell types in situ can be accomplished through the use of immunohistochemical and histochemical techniques. Previously, NADPH-cytochrome P450 reductase and cytochrome P450 2B1 (see 19 for nomenclature) were found to be localized in epithelial cells and Bowman's glands in the olfactory region and in epithelial cells and seromucous glands in the respiratory region of untreated rats (20), whereas cytochrome P450 1Al (21) and an olfactory-specific UDP-glucuronosyltransferase (22) were found in the olfactory epithelium and Bowman's glands of untreated rats. In the present study, the localization and distribution of cytochrome P450 1Al were investigated immunohistochemically in the nasal mucosa of untreated and xenobiotic-pre-treated rats. In conjunction with these analyses, intranasal sites for benzo[ alpyrene hydroxylase activity were identified histochemically to correlate immunohistochemical findings with monooxygenase activity and to determine which cells in the nasal mucosa are capable of oxidatively metabolizing pro-carcinogens and other xenobiotics in situ. Preliminary accounts of parts of these studies have been published elsewhere (23).
Materials and Methods
Materials. 3 ,Y-Diaminobenzidine tetrahydrochloride was purchased from Hach Chemical (Loveland, CO), 3-methylcholanthrene was obtained from Eastman Kodak (Rochester, NY), and Aroclor 1254 was purchased from FoxborolAnalabs (North Haven, CT). Normal (non-immune) rabbit and sheep sera were obtained from Cooper Biomedical (Malvern, PA). Biotinylated rabbit and sheep immunoglobulins directed against sheep and rabbit immunoglobulins, respectively, biotinylated horseradish peroxidase, avidin, and fluorescein isothiocyanate-conjugated avidin were purchased from Vector Laboratories (Burlingame, CA). NADH (Grade 111). NADPH (Type I), glucose-6-phosphate, and glucose-6-phosphate dehydrogenase were obtained from Sigma (St Louis, MO). Benzo[a]pyrene, purchased from Pfaltz and Bauer (Waterbury, CT), was purified by reverse-phase HPLC on an Ultrasphere ODS column (Beckman Instruments; St Louis, MO) using a solvent consisting of 90% methanol:lo% water and monitoring absorbance at 296 nm. All other chemicals were of the highest purity available.
Animals and Pre-treatments. Male Sprague-Dawley rats (Harlan Sprague-Dawley; Indianapolis, IN) weighing 160-180 g were used in this study. Groups of rats were either pre-treated for 5 consecutive days with 3-methylcholanthrene (40 mglkglday IP in corn oil) and sacrificed 24 hr after the last dose, or were administered a single IP dose of Aroclor 1254 (500 mglkg in corn oil) and sacrificed 7 days later. Control rats were either untreated or administered appropriate volumes of vehicle (corn oil). Experiments were conducted according to the University of Iowa institutional guidelines for the care and use of laboratory animals.
Antigens and Antibodies. Procedures for the isolation and purification to apparent homogeneity of rat hepatic microsomal cytochrome P450 1Al (24.25) and NADPH-cytochrome P450 reductase (26) . the preparation of polyclonal antibodies against each enzyme, and the specificities of these antibodies have been described previously. The antLP450 1Al used in this study crossreacts with cytochrome P450 1A2, a form of rat hepatic cytochrome P450 induced by treatment with P-naphthoflavone and isosafrole (27) . Although P450 1A2 is usually not expressed or inducible in extrahepatic tissues of the rat (28) . the expression of this P450 in the rat nasal mucosa has not been studied. Cytochrome P450 1A2 is expressed in the nasal mucosa of untreated rabbits (29) . Although the antLP450 1Al crossreacts with the corresponding enzyme in rat nasal mucosa, it must be emphasized that immunohistochemical staining produced by this antibody in the nasal mucosa may be indicative of the presence of an antigen that is immunochemically similar, rather than identical, to the rat liver enzyme.
Immunohinochemical procedures. After rats were decapitated, the nasal septum and dorsal turbinates were removed, faed at 4'C in a solution con-sisting of 1% acetic acid in 95% ethanol, and processed as previously described (20) . Cytochrome P450 1Al was localized at the light microscopic level in paraffin sections of the nasal mucosa by means of immunoperoxidase (avidin-biotin-peroxidase) (30) as well as immunofluorescence (avihn-fluorescein kothigranate) (31) staining. Both immunohtochemical staining procedures were optimized so that the intensity of staining was limited solely by the antigen's content (32) . The identification of specific cell types in immunohistochemically stained sections was confirmed by examining serial sections that had been stained with hematoxylin and eosin.
To determine the intranasal distribution of cytochrome P450 1A1, the relative extents to which the antLP450 1Al bound to different nasal mucosal cells were determined after completion of immunofluorescence staining (31) . Briefly. microfluorometric measurements were obtained from within 7-wm2 circular areas in the apical cytoplasmic region of olfactory and respiratory epithelial cells and in the cytoplasm of Bowman's glands acinar cells in the olfactory region and seromucous gland duct cells in the respiratory region. The extent of anti-P450 1Al binding to a given cell type was determined by subtracting the mean intensity of fluorescence emitted from within cells in sections exposed to normal serum from the mean intensity of fluorescence emitted from within corresponding cells in serial sections exposed to an equivalent dilution of rabbit anti-P450 1Al. Measurements were obtained from at least 10 randomly chosen cells of each cell type in a minimum of two tissue sections from each animal. Mean antibody binding was determined from measurements obtained using sections from at least nine untreated rats and at least seven rats in each treatment group. Antibody binding values were analyzed using a one-way analysis of variance and Tukey's w procedure.
Histochemical Demonstration of Benzo[a]pyrene Hydroxylase Activity. Sites at which benzo[ alpyrene undergoes hydroxylation in situ within the nasal mucosa of untreated and xenobiotic pretreated rats were identified by a previously described fluorescence histochemical procedure (31) . Briefly, unfixed cryostat sections, 6 pm in thickness, were dipped into acetone containing 20 pM benzo[a]pyrene. After evaporation of the acetone, the sections were incubated for 1 hr at 37'C in 50 mM potassium phosphate, pH 7.4, containing 0.58 mM NADPH, 0.11 mM NADH, 1.6 mM glucose-6-phosphate, and 1 U of glucose-6-phosphate dehydrogenase. To demonstrate the involvement of enzymes in the monooxygenation reaction, some sections were dipped into the benzo[a]pyrene solution, dried, and then exposed to antiserum raised against either cytochrome P450 1Al or NADPH-cytochrome P450 reductase for 2 hr at 37'C before incubation with co-factors. In control experiments, other sections were incubated in the absence of reduced pyridine nucleotides. After incubation, sections were rinsed and mounted in alkaline glycerol, pH 8.2, and fluorescent phenolic benzo[a]pyrene metabolites were visualized by means of incident-light fluorescence microscopy (31) .
Results

Localization of Cytochrome P450 1Al and Benzo[a]pyrene Hydroxylase Activity in the Nasal Mucosa of Untreated Rats
The exposure of sections prepared from, fixed, paraffin-embedded nasal tissues of untreated male Sprague-Dawley rats to the antiserum raised against rat hepatic microsomal cytochrome P450 1Al resulted in the appearance of immunohistochemical staining in Bowman's glands and, to a lesser degree, in the apical region of the olfactory epithelium ( Figure E ). Considerably less staining was evident in the epithelium and seromucous glands in the respiratoty region, however ( Figure 1F ). Specific staining for cytochrome P450 C Figure 1 . lmmunoperoxidase staining for cytochrome P450 1Al within olfactory and respiratory regions in the nasal mucosa of untreated rats. (A.C.E) The same area of an olfactory region in serial sections. (B,D,F) The same area of a respiratory region in serial sections. (A,B) Sections stained with hematoxylin and eosin: (C.D) sections exposed to normal rabbit serum; (E.F) sections exposed to rabbit antiserum raised against rat hepatic cytochrome P450 1Al. Arrowhead in F, duct cells. Bar = 100 pm.
1Al was not apparent in connective tissue, blood vessels, or nerve bundles. In addition, little if any immunohistochemical staining was observed when sections were exposed to normal serum ( Figures  1C and ID) , as well as when the antLP450 1Al serum was replaced with adsorbed antiserum (data not shown). Visually, cells in Bowman's glands clearly appeared to be stained much more intensely than were others in the nasal mucosa. This observation was confirmed by the results of microfluorometric analyses of immunofluorescence staining intensities (Table 1) . which revealed that much more anti-P450 1Al bound to Bowman's gland cells than to olfactory and respiratory epithelial cells and to cells associated with seromucous gland ducts.
The incubation of unfixed cryostat sections prepared from the nasal mucosa of untreated rats with benzo[ alpyrene and reduced pyridine nucleotides resulted in the generation of fluorescent phenolic metabolites from the polycyclic aromatic hydrocarbon (Figure 2) . Visually, benzo[a]pyrene appeared to be hydroxylated to the greatest extent in Bowman's glands and, to a lesser extent, in the apical region of the olfactory epithelium (Figure 2A ). Little if any hydroxylase activity, however, was detectable in the respiratory region ( Figure 2B ) or in either the olfactory or respiratory regions when sections were incubated in the absence of pyridine nucleotides ( Figures 2C and 2D) .
To demonstrate the involvement of cytochrome P450 1Al and NADPH-cytochrome P450 reductase in the in situ hydroxylation of benzo[ ajpyrene in the nasal mucosa, benzo[ alpyrene-coated sec- Table 1 tions were pre-incubated with antiserum to either NADPH-cytochrome P450 reductase or cytochrome P450 1Al before incubation with pyridine nucleotides and the reduced pyridine nucleotide-generating system. The incubation of sections with anti-NADPH-cytochrome P450 reductase dramatically inhibited the benzo[a]pyrene hydroxylase activity in the olfactory region ( Figure 2E ). Similarly, the exposure of sections to antLP450 1Al inhibited the hydroxylation reaction in the olfactory region ( Figure 2G ), although the degree of inhibition did not appear to be as complete as that produced by the anti-NADPH-cytochrome P450 reductase.
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Effects of Aroclor 1.254 and 3-Methylcholanthrene on Nasal Cytochrome P4SO 1Al and Benzo[a]pyrene Hydroxylase Activity
The pre-treatment of rats with 3-methylcholanthrene (administered IP in corn oil at a dose of 40 mg/kg/day for 5 consecutive days) did not result in alterations in either cytochrome P450 1Al (Figures 3G and 3H; Tible 1) or benzo[a]pyrene hydroxylase activity ( Figures  4G and 4H) in the nasal mucosa. In marked contrast, 7 days after the IP administration of a single 500-mg/kg dose of Aroclor 1254 in corn oil, a pronounced induction of cytochrome P450 1Al was readily detected in the olfactory and respiratory epithelia as well as in Bowman's glands, but not in seromucous glands (Figures 3E and 3F Tible 1). Although Aroclor 1254 increased cytochrome P450 1Al levels in both the olfactory and respiratory regions of the nasal mucosa, the olfactory region still contained the greatest amount of this form of cytochrome P450 (Figure 3 , Table 1 ).
Aroclor 1254 also produced a marked induction of benzo[a]pyrene hydroxylase activity in the nasal mucosa ( Figures 4E and  4F) . In contrast to its effects on cytochrome P450 1A1, however, Aroclor induced the monooxygenase activity in the seromucous glands, as well as in the olfactory and respiratory epithelia and Bowman's glands ( Figures 4E and 4F) . Moreover, the enhancement of activity in the respiratory region was much greater than that produced in the olfactory region. In fact, after the administration of this mixture of polychlorinated biphenyls, benzo[ alpyrene hydroxylase activity appeared to become distributed quite evenly between the olfactory and respiratory regions of the nasal mucosa. The increase in benzo[a]pyrene hydroxylase activity after Aroclor 1254 treatment appeared to be due to an increase in the expression of P450, based on the increased staining for cytochrome P450 1Al ( Figure  3 ) and the absence of any alteration in the localization of NADPHcytochrome P450 reductase after Aroclor 1254 or 3-methylcholanthrene pre-treatment (data not shown).
Discussion
Many xenobiotics that damage the nasal mucosa after inhalation or systemic administration are oxidatively metabolized to cytotoxic or genotoxic intermediates by cytochromes P450. Cytochrome P450 1A1, the major form of cytochrome P450 induced in hepatic microsomes by 3-methylcholanthrene, catalyzes the oxidation of many xenobiotics, including polycyclic aromatic hydrocarbons and dimethylnitrosamine (27) . The results of the present study demonstrate that cytochrome P450 1Al is primarily localized in Bowman's glands in the nasal mucosa of untreated rats, confirming the findings of Foster et al. (21) , who found staining for cytochrome P450 1Al in Bowman's glands and the olfactory epithelium. Non-ciliated cuboidal cells of the transitional epithelium, which were not investigated in this study, have also been reported to contain significant amounts of cytochrome P450 lAl (33) . In contrast, cytochrome P450 2B1, the major form of cytochrome P-450 induced in hepatic microsomes by phenobarbital, and NADPH-cytochrome P450 reductase were previously found to be distributed quite uniformly throughout the epithelia and glands of both the olfactory and respiratory regions in untreated rats (20) . It is therefore apparent that . (A,C,E,G) Olfactory regions; (B,D,F,H) respiratory regions. (A,B,E-H ) Sections exposed to benzo[a]pyrene and incubated in buffer containing NADPH, NADH, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase. (C,D) Sections exposed to benzo[a]pyrene but incubated in the absence of pyridine nucleotides.
(E,F) Sections exposed to sheep antiserum to rat hepatic NADPH-cytochrome P450 reductase before incubation. (G,H) Sections exposed to rabbit antiserum to rat hepatic cytochrome P450 1Al before incubation. Bar = 100 pm.
RAT NASAL CYTOCHROME P450 1Al AND AHH ACTMTY the !ocalizations of different cytochromes P450 within the nasal mucosa of untreated rats vary dramatically.
The benzo[a]pyrene hydroxylase assay used in the present study is based on the visualization of fluorescent phenolic metabolites formed by cytochrome P450. Benzo[a]pyrene can also be metabolized by rat nasal tissue to many other products, including diols, tetrols, quinones, diones (lo), and unidentified mutagenic products (34) . The localization of benzo[a]pyrene hydroxylase activity in the olfactory region of untreated rats closely paralleled the distribution of cytochrome P450 1Al in Bowman's glands and the 01factory epithelium. The inhibitory effect of antLP450 1Al on benzo[a]pyrene hydroxylase activity suggests that the majority of the benzo(a1pyrene hydroxylase activity in the nasal mucosa of untreated rats is catalyzed by a cytochrome P450 that is immunochemically similar to cytochrome P450 1Al.
Although it is apparent that Bowman's glands contain cyto-chrome P450, the specific identity of the cells in the epithelium that contain cytochrome P450 is unclear. It was not possible to unambiguously identdy individual cell types in the epithelia at the light microscopic level. The localization of immunohistochemical staining and hydroxylase activity primarily in the apical region of the epithelium does correspond with the location of the majority of the cytoplasm associated with sustentacular cells (35) , suggesting that these epithelial cells contain cytochrome P450 1Al. At present, however, the possibility that olfactory neuronal cells also contain cytochrome P450 1Al cannot be ruled out. Previous studies failed to detect induction of cytochrome P450-dependent activity in nasal mucosal homogenates of Aroclor 1254or 3-methylcholanthrene-pre-treated rats (10) or in nasal mucosal microsomes from 3-methylcholanthrene-pre-treated rats (36) . Even the high dose of 3-methylcholanthrene used in the present study (40 mglkglday for 5 days), which is more than sufficient to induce hepatic cytochrome P450 IAl (37) . failed to affect either cytochrome P450 1Al or benzo[a]pyrene hydroxylase activity in the nasal mucosa.
Although it is possible that the amount of 3-methylcholanthrene reaching the nasal mucosa after IP administration was insufficient to induce this protein, other investigators have failed to detect induction of nasal cytochrome P450 after direct instillation of 3-methylcholanthrene ( 5 mg/kg/day for 2 days) into the noses of rats (36), suggesting that 3-methylcholanthrene is not an inducer of cytochrome P450 in nasal tissue. In contrast to 3-methylcholanthrene, Aroclor 1254 produced significant changes in the intensity of immunostaining for both cytochrome P450 1Al and benzo[a]pyrene hydroxylase activity within the nasal mucosa. The dose of Aroclor 1254 used (500 mglkg on Day 1 with sacrifice on Day 7) was greater than the dose (200 mg/kg on Day 1 with sacrifice on Day 5 ) that failed to cause induction of nasal cytochrome P450 in a previous study (10) . After Aroclor 1254-pre-treatment, benzo[ alpyrene hydroxylase activity was evenly distributed between the olfactory and respiratory regions, whereas immunostaining for P450 1Al remained greater in the olfactory region. These results suggest that Aroclor 1254 induces one or more forms of cytochrome P450, other than P450 1A1, which catalyze the hydroxylation of benzo[ alpyrene in the respiratory region of the nasal mucosa. The cross-reactivity of the antibody to cytochrome P450 1Al with P450 1A2 raises the possibility that one of these forms could be P450 1A2, although cytochrome P450 1A2 has not been detected in extrahepatic tissues (28) , and generally has benzo[a]pyrene hydrocarbon hydroxylase activity that is an order of magnitude lower than that of P450 1Al (27, 38) .
Several forms of cytochrome P450, which appear to be expressed only in nasal tissue of rats, have recently been identified. Although one of these, P450 2G1. is localized primarily in Bowman's glands in nasal tissue from untreated rats (39, neither the ability of this form to catalyze the hydroxylation of benzo[a]pyrene nor the effects of inducing agents on the expression of P450 2G1 have been characterized. Further study will be required to elucidate the functions of these nasal mucosa-specific cytochromes P450 in xenobiotic metabolism and to determine how their expressions are regulated.
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